# Basis: Evaluating Sirtuin Supplements To Benefit Elderly Trauma Patients (BES2T BET)

> **NCT03635411** · PHASE1 · UNKNOWN · sponsor: **Elysium Health** · enrollment: 48 (estimated)

## Conditions studied

- Recovery of Function

## Interventions

- **DIETARY_SUPPLEMENT:** Nicotinamide Riboside and Pterostilbene
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT03635411
- **Lead sponsor:** Elysium Health
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-12-06
- **Primary completion:** 2020-11
- **Final completion:** 2020-12
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2020-01-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03635411

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03635411, "Basis: Evaluating Sirtuin Supplements To Benefit Elderly Trauma Patients (BES2T BET)". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT03635411. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*